Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2012 /
Collaborations in clinical trials to bring new drugs to patients earlier

4th - 7th Nov 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.11.12
Views: 3271

Dr Matt Seymour – National Cancer Research Network

Dr Matt Seymour discusses how the National Cancer Research Network is acting to build collaborations between UK clinical studies groups and pharmaceutical companies to allow patients to access new therapeutic agents at an earlier stage. Dr Seymour explains how the Experimental Cancer Medicine Network is facilitating the simultaneous operation of phase II studies with clinical trials assessing potential combination therapies, outlines the problems that have emerged and the steps that have been taken to overcome these.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation